http://www.iii.co.uk/investment/detail?code=cotn:GWP.L&display=news http://www.iii.co.uk/investment/detail?code=cotn:GWP.L&display=news&action=article&articleid=8595436&from=rss RNS Number : 9724DGW Pharmaceuticals PLC23 May 2012  GW Pharmaceuticals PLC Director/PDMR Shareholding GW Pharmaceuticals PLC 23 May 2012 GW Pharmaceuticals PLC GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company") NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED... Wed, 23 May 2012 15:56:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:GWP.L&display=news&action=article&articleid=8593100&from=rss RNS Number : 7989DGW Pharmaceuticals PLC22 May 2012     THIRD PHASE III SATIVEX® CANCER PAIN TRIAL COMMENCES Porton Down, UK; 22 May 2012: GW Pharmaceuticals plc (AIM: GWP) today announced the initiation of a third Phase III Sativex® clinical trial in the treatment of pain... Tue, 22 May 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:GWP.L&display=news&action=article&articleid=8593065&from=rss RNS Number : 7988DGW Pharmaceuticals PLC22 May 2012   GW Pharmaceuticals plc   Interim Results   Porton Down, UK, 22 May 2012: GW Pharmaceuticals plc (AIM: GWP, "GW" or "the Group"), the specialty pharmaceutical company focused on cannabinoid science, announces its... Tue, 22 May 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:GWP.L&display=news&action=article&articleid=8578368&from=rss RNS Number : 8075CGW Pharmaceuticals PLC08 May 2012   Sativex® Mutual Recognition Procedure Closes with Recommendation for Approval in Ten European Countries   ·     Sativex® is already available in the UK, Spain, Germany and Denmark. Launches currently in preparation in... Tue, 08 May 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:GWP.L&display=news&action=article&articleid=8568314&from=rss RNS Number : 1344CGW Pharmaceuticals PLC26 April 2012   GW Pharmaceuticals plc     Notification of Results   Porton Down, UK, 26 April 2012: GW Pharmaceuticals plc (AIM: GWP) will be announcing its interim financial results for the six months ended 31 March 2012 on Tuesday 22 May... Thu, 26 Apr 2012 11:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:GWP.L&display=news&action=article&articleid=8563587&from=rss RNS Number : 8158BGW Pharmaceuticals PLC23 April 2012   Publication of full Sativex® phase IIb pain trial results in official journal of the American Pain Society   London, UK; Tokyo, Japan; April 23 2012: GW Pharmaceuticals plc (AIM: GWP) and Otsuka Pharmaceutical Co.,... Mon, 23 Apr 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:GWP.L&display=news&action=article&articleid=8556381&from=rss RNS Number : 3495BGW Pharmaceuticals PLC16 April 2012   €11.9 MILLION MILESTONE PAYMENT     Porton Down, UK; 16 April 2012: GW Pharmaceuticals plc (AIM: GWP) confirms that it has now earned the €11.9 million milestone payment due as a result of the recently... Mon, 16 Apr 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:GWP.L&display=news&action=article&articleid=8549327&from=rss RNS Number : 8726AGW Pharmaceuticals PLC05 April 2012   Board Changes   Porton Down, UK; 5 April 2012: GW Pharmaceuticals plc (AIM: GWP) announces that, after ten years as Finance Director, David Kirk has informed the Company that he intends to stand down from the Board... Thu, 05 Apr 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:GWP.L&display=news&action=article&articleid=8545672&from=rss RNS Number : 6226AGW Pharmaceuticals PLC02 April 2012    GW Pharmaceuticals PLC     GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")   NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS                                                                        ... Mon, 02 Apr 2012 14:31:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:GWP.L&display=news&action=article&articleid=8543792&from=rss RNS Number : 4932AGW Pharmaceuticals PLC30 March 2012     GW Pharmaceuticals PLC Director/PDMR Shareholding GW Pharmaceuticals PLC 30 March 2012 GW Pharmaceuticals PLC GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company") NOTIFICATION OF INTERESTS OF DIRECTORS... Fri, 30 Mar 2012 13:57:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:GWP.L&display=news&action=article&articleid=8527493&from=rss RNS Number : 3858ZGW Pharmaceuticals PLC15 March 2012   GW AND ALMIRALL STRENGTHEN STRATEGIC COLLABORATION   ·     Financial terms amended to provide for near term €12m (£10m) milestone payment to GW   ·     Almirall granted commercial rights to Sativex® for Mexican ... Thu, 15 Mar 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:GWP.L&display=news&action=article&articleid=8520522&from=rss RNS Number : 9236YGW Pharmaceuticals PLC08 March 2012   PROFESSOR VINCENZO DI MARZO TO DIRECT GW'S GLOBAL PRE-CLINICAL RESEARCH PROGRAMME   Porton Down, UK; 8 March 2012: GW Pharmaceuticals plc (AIM: GWP) today announces that, effective March 1st 2012, Professor Vincenzo... Thu, 08 Mar 2012 07:00:00 GMT